Skip to main content
SpringerLink
Log in

No effect of diltiazem on the hepatic clearance of indocyanine green in the rats

  • Research Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

In order to investigate the effect of the pretreatment with various doses of diltiazem (DTZ) on the pharmacokinetics of indocyanine green (ICG) at steady state, especially the hepatic blood clearance due to the change of hepatic blood flow, the following experiments were carried out with ICG, a hepatic function test marker, not metabolized in liver and only excreted in bile. The intravenous bolus injection (3,780 μg/kg) and the constant-rate infusion (10, 100 μg/kg/hr) or ICG into the left femoral vein were made in order to check the steady-state plasma concentration (C ss of 10 μg/ml) of ICG at 20, 25 and 30 min. Following a 90-min washout period, the intravenous bolus injection (108, 430, 860 and 1,720 μg/kg) and the constant-rate infusion (108, 433, 866 and 1,730 μg/kg/hr) of DTZ into the right femoral vein were made and the achievement of the steady-state plasma levels (C ss of 50, 200, 400 and 800 ng/ml) of DTZ were conformed at 60, 70 and 80 min. During the steady state of DTZ, the intravenous bolus injection (3,780 μg/kg) and the constant-rate infusion (10,200 μg/kg/hr) of ICG into the left femoral vein were made and also the steady-state plasma concentration of ICG was checked at 20, 25 and 30 min. The plasma concentrations of DTZ and ICG were determined using a high performance liquid chromatographic technique. At the steady state, the hepatic blood clearance of ICG was obtained from the plasma concentration and blood-to-plasma concentration ratio (R b ) of ICG. The pretreatment with various doses of DTZ did not influence the plasma concentrations,R B and plasma free fraction (f p ) of ICG. So the hepatic blood clearance of ICG was independent of concentration of DTZ. The hepatic blood clearance of ICG could be affected by both hepatic blood flow and hepatic intrinsic clearance. But there was no change of the hepatic blood clearance of ICG between the control and the DTZ-pretreated rats in this study. So it may be suggested that DTZ does not influence hepatic blood flow.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References Cited

  • Antman, E. M., Stone, P. H., Muller, J. E. and Braunwald, E., Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects.Ann. Intern. Med., 93, 875–885 (1980).

    PubMed  CAS  Google Scholar 

  • Baker, K. J., Binding of sulfobromophthalein (BSP) and indocyanine green (ICG) to plasma α1-lipoproteins.Proc. Soc. Exp. Biol. Med., 122, 957–963 (1966).

    PubMed  CAS  Google Scholar 

  • Bauer, L. A., Stenwall, M., Horn, J. R., Davis, R., Opheim, K. and Greene, L., Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.J. Clin. Pharmacol., 40, 239–242 (1986).

    CAS  Google Scholar 

  • Bourassa, M. G., Cote, P., Theroux, P., Tubau, J. F., Genain, C. and Waters, D. D., Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans.Chest, 78, 224–230 (1980).

    PubMed  CAS  Google Scholar 

  • Caesar, J., Shaldon, S., Chaindussi, L., Guevara, L. and Sherlock, S., The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.Clin. Sci. 21, 43–57 (1961).

    PubMed  CAS  Google Scholar 

  • Chaffman, M. and Brogden, R. N., Diltiazem: A review of its pharmacological properties and therapeutic efficacy.Drugs, 29, 387–454 (1985).

    Article  PubMed  CAS  Google Scholar 

  • Daemen, M. J. A. P., Thijssen, H. H. W., van Essen, H., Vervoort-Peters, H. T. M., Prinzen, F. W., Struyker, H. A. J. and Smits, J. F. M., Liver blood flow measurement in the rat.J. Pharmacol. Meth., 21, 287–297 (1989).

    Article  CAS  Google Scholar 

  • Daneshmend, T. K., Jackson, L. and Roberts, C. J. C., Physiological and pharmacological variability in estimated hepatic blood flow in man.Br. J. Clin. Pharmacol. 11, 491–496 (1981).

    PubMed  CAS  Google Scholar 

  • Dorr, M. B. and Pollack, G. M., Specific assay for the quantitation of indocyanine green in rat plasma using high performance liquid chromatography with fluorescence detection.J. Pharm. Sci., 78, 828–833 (1989).

    Article  Google Scholar 

  • Flaim, S. F. and Zelis, R., Regional distribution of cardiac output in conscious rats at rest and during exercise: Effects of diltiazem.Chest, 78, 187S-192S (1980).

    Google Scholar 

  • Flaim, S. F. and Zelis, R., Effects of diltiazem on total cardiac output distribution in conscious rats.J. Pharm. Exp. Ther., 222, 359–366 (1982).

    CAS  Google Scholar 

  • Freely, J., Nifedipine increases and glyceryl trinitrate decreases apparent liver blood flow in normal subjects.Br. J. Clin. Pharmacol., 17, 83–85 (1984).

    Google Scholar 

  • Gibaldi, M. and Perrier, D.,Pharmacokinetics, Marcel Dekker, New York, 1982.

    Google Scholar 

  • Goebel, K. J. and Kolle, E. U., High performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma.J Chromatogr. 345, 355–363 (1985).

    Article  PubMed  CAS  Google Scholar 

  • Grainger, S. L., Keeling, P. W. N., Brown, I. M. H., Marigold, J. H. and Thompson, R. P. H., Clearance and noninvasive determination of the hepatic extraction of indocyanine green in baboons and man.Clin. Sci., 64, 207–212 (1983).

    PubMed  CAS  Google Scholar 

  • Isanta, J. R., Lasheras, B., Fos, D. and Cenarruzabeitia, E., Comparative diltiazem plasma clearance in normotensive and hypertensive rats.J. Pharm. Sci., 76, 862–865 (1987).

    PubMed  CAS  Google Scholar 

  • Klaassen, C. D. and Plaa, G. L., Plasma disappearance and biliary excretion of indocyanine green in rats, rabbits and dogs.Toxicol. Appl. Pharmacol., 15, 374–384 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Kraft, W., Lechner, J., Vollmar, A. M., Reusch, C., Warmbier, M. and Lohss, E., Indozyaningruntest beim Hund.Tierärztl. Prax., 19, 439–446 (1991).

    PubMed  CAS  Google Scholar 

  • Lee, Y. B., Koh, I. B. and Lee, M. H., The effect of phenobarbital pretreatment on the pharmacokinetics of diltiazem in rats.J. Kor. Pharm. Sci., 22, 219–227 (1992).

    CAS  Google Scholar 

  • Lee, Y. B., Pharmacokinetic analysis of the effect of phenobarbital on the hepatic transport of indocyanine green.Ph. D. Thesis, Seoul National University, Seoul, Korea (1993)

    Google Scholar 

  • McDevitt, D. G., Nies, A. S. and Wilkinson, G.R., Influence of phenobarbital on factors responsible for hepatic clearance of indocyanine green in the rat.Biochem. Pharmacol., 26, 1247–1250 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Meredith, P. A., Elliott, H. L., Pasanisi, F., Kelman, A. W., Sumner, D. J. and Reid, J. L., Verapamil pharmacokinetics and apparent hepatic and renal blood flow.Br. J. Clin. Pharmacol., 20, 101–106, (1985).

    PubMed  CAS  Google Scholar 

  • Nagao, T., Narita, H., Sato, M. Nakajima, H. and Kiyomoto, A., Development of diltiazem, a calcium antagonist: Coronary vasodilating and hypotensive actions.Clin. Exp. Hyperten. A4, 285–296 (1982).

    Article  CAS  Google Scholar 

  • Narita, H., Nagao, T. Yabana, H. and Yamaguchi, I., Hypotensive and diuretic actions of diltiazem in spontaneously hypertensive and Wistar Kyoto rats.J. Pharmacol. Exp. Ther., 227, 472–477 (1983).

    PubMed  CAS  Google Scholar 

  • Pang, K. S. and Rowland, M., Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J. Pharmacokinet. Biopharm., 5, 625–653 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Paumgartner, G., Probst, P., Kraines, R. and Leevy, C. M., Kinetics of indocyanine green removal from the blood.Ann. N. Y. Acad. Sci., 170, 134–147 (1970).

    Article  CAS  Google Scholar 

  • Pollack, G. M. and Brouwer, K. L. R., Thermal injury decreases hepatic blood flow and the intrinsic clearance of indocyanine green in the rat.Pharm. Res., 8, 106–111 (1991).

    Article  PubMed  CAS  Google Scholar 

  • Pollack, G. M., Brouwer, K. L. R., Demby, K. B. and Jones, J. A., Determination of hepatic blood flow in the rat using sequential infusions of indocyanine green or galactose.Drug Met. Disposit., 18, 197–202 (1990).

    CAS  Google Scholar 

  • Roberts, R. K., Heath, C. A., Johnson, R. F., Speeg, K. V. and Schenker, S., Effect of H2-receptor antagonists on steady-state extraction of indocyanine green and lidocaine by the perfused rat liver.J. Lab. Clin. Med., 107, 112–117 (1986).

    PubMed  CAS  Google Scholar 

  • Sato, M., Nagao, T., Yamaguchi, I., Nakajima, H. and Kiyomoto, A., Pharmacological studies on a new 1, 5-benzothiazepine derivative (CRD-401).Arzneim.-Forsch., 21, 1338–1343 (1971).

    CAS  Google Scholar 

  • Skak, C. and Keiding, S., Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man.Liver, 7, 155–162 (1987).

    PubMed  CAS  Google Scholar 

  • Skerjanec, A., O'Brien, D. W. and Tam, Y. K., Hepatic blood flow measurements and indocyanine green kinetics in a chronic dog model.Pharm. Res., 11, 1511–1515 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Stone, P. H., Antman, E. M., Muller, J. E. and Braunwald, E., Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II. Hemodynamic effects and clinical applications.Ann. Intern. Med. 93, 866–904 (1980).

    Google Scholar 

  • Tozer, T. N., Gambertoglio, J. G., Furst, D. E., Avery, D. S. and Holford, N. H. G., Volume shifts and protein binding estimates using equilibrium dialysis. Application to prednisolone binding in humans.J. Pharm. Sci., 72, 1442 (1983).

    Article  PubMed  CAS  Google Scholar 

  • Zelis, R. and Schroeder, J. S., Symposium on calcium, calcium antagonists, and cardiovascular disease.Chest, 78, 121–247 (1980).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Institute of Drug Development, Chonnam National University, 500-757, Kwangju, Korea

    Eun-Hee Joo & Yong-Bok Lee

  2. College of Pharmacy, Chonnam National University, 300 Yongbong Dong, 500-757, Kwangju, Korea

    Eun-Hee Joo & Yong-Bok Lee

Authors
  1. Eun-Hee Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yong-Bok Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joo, EH., Lee, YB. No effect of diltiazem on the hepatic clearance of indocyanine green in the rats. Arch. Pharm. Res. 21, 411–417 (1998). https://doi.org/10.1007/BF02974635

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02974635

Key words

Search

Navigation